G - Physics – 01 – N
Patent
G - Physics
01
N
167/44
G01N 33/569 (2006.01) C07K 14/15 (2006.01) G01N 33/543 (2006.01)
Patent
CA 2034611
The present invention relates to a method for the detection HTLV-I and/or HTLV-II reactive antibodies and diagnosis of ATL (adult T cell leukemia/lymphoma) condition by the use of chemically synthesized peptide compositions. The peptide compositions comprise peptides having amino acid sequences corresponding to transmembrane and external segments of the envelope protein of HTLV-I/HTLV-II and mixtures thereof. The peptide compositions are highly immunoreactive with antibodies to HTLV in sera. The present invention further relates to a method for the simultaneous detection and diagnosis of ATL, HTLV-I and/or HTLV-II infection and Acquired Immune Deficiency Syndrome (AIDS) by the use of chemically synthesized HTLV peptide compositions in conjunction with a chemically synthesized HIV (1 and 2) peptide composition. The present invention also provides a simple method to differentiate between HTLV-I and HTLV-II infections. The detection method includes an enzyme-linked immunosorbent assay (ELISA), an immunoradiometric assay (IRMA), and other forms of immunoassay procedures such as enzyme immuno blotting assay on nitrocellulose paper and an agglutination assay using the peptide composition as the antigen. The preferred detection method is ELISA.
Macrae & Co.
United Biomedical Inc.
LandOfFree
Synthetic peptide compositions with immunoreactivities to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic peptide compositions with immunoreactivities to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic peptide compositions with immunoreactivities to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1354475